
|Videos|March 30, 2022
Prognostic Value of Biomarkers in RCC
Author(s)Robert S. Alter, MD
Robert Alter, MD opines on the current prognostic value of biomarkers for RCC and the need for additional data in the field.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Half a Year Into the Breast Biopsy Needle Shortage, Clinicians Lean on Networks, Not Workarounds
2
How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?
3
Study Redefines Functional High-Risk Multiple Myeloma in Modern-Therapy Era
4
First-in-Human mKRAS Vaccine Elicits Durable T-Cell Responses in High-Risk PDAC
5

































































